Cho, Sang-Geon <br/><br/>
What is the optimal cardiac screening for asymptomatic transthyretin gene mutation carriers?  [electronic resource] 

 -  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology  10 2021 
 - 1958-1960 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>1532-6551 
<br/><br/><label>Standard No.: </label>10.1007/s12350-019-01970-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amyloid Neuropathies, Familial--diagnostic imaging<br/>Cardiomyopathies--diagnostic imaging<br/>Disease Progression<br/>Humans<br/>Mutation--genetics<br/>Myocardial Perfusion Imaging<br/>Organotechnetium Compounds<br/>Prealbumin--genetics<br/>Predictive Value of Tests<br/>Reproducibility of Results<br/>Sensitivity and Specificity<br/>Sulfur Compounds<br/>Time Factors